X-103776997-T-G
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_000533.5(PLP1):c.2T>G(p.Met1?) variant causes a start lost, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000533.5 start_lost, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 27
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 2 Pathogenic:2
- -
Variant summary: PLP1 c.2T>G (p.Met1Arg) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. An alternative downstream in-frame start codon (Met206) is located in the encoded protein. An activation of potential downstream translation at this initiation site would result in a shortened protein missing the first 205 amino acids from the protein sequence. Three of four in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 180287 control chromosomes (gnomAD). c.2T>G has been reported in the literature in the hemizygous state multiple male individuals affected with Hereditary spastic paraplegia 2 and has been found to segregate with the disease phenotype in an X-linked manner within families (e.g. Hand_2012, Hebbar_2019). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 22343157, 30337681). One submitter has cited a clinical-significance assessment for this variant to ClinVar after 2014 and has classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Inborn genetic diseases Pathogenic:1
- -
Pelizaeus-Merzbacher disease Pathogenic:1
This missense variant (c.2T>G, p.Met1Arg) has not been observed in population databases (gnomAD). It has been described in the literature (PMID 22343157), and other changes that alter the initiation codon have also been reported (PMID 10417279, 8786077, 12910435). Variant prediction programs suggest a deleterious effect on the PLP1 protein, but no functional studies have been published. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at